Search

Your search keyword '"Petti, Allegra A."' showing total 49 results
Start Over Author "Petti, Allegra A." Publisher american association for cancer research (aacr)
49 results on '"Petti, Allegra A."'

1. Glioblastoma-infiltrating CD8+ T cells are predominantly a clonally expanded GZMK+ effector population

Author

Wang, Anthony Z., primary, Mashimo, Bryce L., additional, Schaettler, Maximilian O., additional, Sherpa, Ngima D., additional, Leavitt, Lydia A., additional, Livingstone, Alexandra J., additional, Khan, Saad M., additional, Li, Mao, additional, Anzaldua-Campos, Markus I., additional, Bradley, Joseph D., additional, Leuthardt, Eric C., additional, Kim, Albert H., additional, Dowling, Joshua L., additional, Chicoine, Michael R., additional, Jones, Pamela S., additional, Choi, Bryan D., additional, Cahill, Daniel P., additional, Carter, Bob S., additional, Petti, Allegra A., additional, Johanns, Tanner M., additional, and Dunn, Gavin P., additional

Published
2024
Full Text
View/download PDF

2. Supplementary Table from Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid Leukemia

Author

Petti, Allegra A., primary, Khan, Saad M., primary, Xu, Ziheng, primary, Helton, Nichole, primary, Fronick, Catrina C., primary, Fulton, Robert, primary, Ramakrishnan, Sai M., primary, Nonavinkere Srivatsan, Sridhar, primary, Heath, Sharon E., primary, Westervelt, Peter, primary, Payton, Jacqueline E., primary, Walter, Matthew J., primary, Link, Daniel C., primary, DiPersio, John, primary, Miller, Christopher, primary, and Ley, Timothy J., primary

Published
2023
Full Text
View/download PDF

3. Supplementary Table from Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid Leukemia

Author

Petti, Allegra A., primary, Khan, Saad M., primary, Xu, Ziheng, primary, Helton, Nichole, primary, Fronick, Catrina C., primary, Fulton, Robert, primary, Ramakrishnan, Sai M., primary, Nonavinkere Srivatsan, Sridhar, primary, Heath, Sharon E., primary, Westervelt, Peter, primary, Payton, Jacqueline E., primary, Walter, Matthew J., primary, Link, Daniel C., primary, DiPersio, John, primary, Miller, Christopher, primary, and Ley, Timothy J., primary

Published
2023
Full Text
View/download PDF

4. Supplementary Table from Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid Leukemia

Author

Petti, Allegra A., primary, Khan, Saad M., primary, Xu, Ziheng, primary, Helton, Nichole, primary, Fronick, Catrina C., primary, Fulton, Robert, primary, Ramakrishnan, Sai M., primary, Nonavinkere Srivatsan, Sridhar, primary, Heath, Sharon E., primary, Westervelt, Peter, primary, Payton, Jacqueline E., primary, Walter, Matthew J., primary, Link, Daniel C., primary, DiPersio, John, primary, Miller, Christopher, primary, and Ley, Timothy J., primary

Published
2023
Full Text
View/download PDF

5. Supplementary Table from Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid Leukemia

Author

Petti, Allegra A., primary, Khan, Saad M., primary, Xu, Ziheng, primary, Helton, Nichole, primary, Fronick, Catrina C., primary, Fulton, Robert, primary, Ramakrishnan, Sai M., primary, Nonavinkere Srivatsan, Sridhar, primary, Heath, Sharon E., primary, Westervelt, Peter, primary, Payton, Jacqueline E., primary, Walter, Matthew J., primary, Link, Daniel C., primary, DiPersio, John, primary, Miller, Christopher, primary, and Ley, Timothy J., primary

Published
2023
Full Text
View/download PDF

6. Supplementary Table from Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid Leukemia

Author

Petti, Allegra A., primary, Khan, Saad M., primary, Xu, Ziheng, primary, Helton, Nichole, primary, Fronick, Catrina C., primary, Fulton, Robert, primary, Ramakrishnan, Sai M., primary, Nonavinkere Srivatsan, Sridhar, primary, Heath, Sharon E., primary, Westervelt, Peter, primary, Payton, Jacqueline E., primary, Walter, Matthew J., primary, Link, Daniel C., primary, DiPersio, John, primary, Miller, Christopher, primary, and Ley, Timothy J., primary

Published
2023
Full Text
View/download PDF

7. Supplementary Table from Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid Leukemia

Author

Petti, Allegra A., primary, Khan, Saad M., primary, Xu, Ziheng, primary, Helton, Nichole, primary, Fronick, Catrina C., primary, Fulton, Robert, primary, Ramakrishnan, Sai M., primary, Nonavinkere Srivatsan, Sridhar, primary, Heath, Sharon E., primary, Westervelt, Peter, primary, Payton, Jacqueline E., primary, Walter, Matthew J., primary, Link, Daniel C., primary, DiPersio, John, primary, Miller, Christopher, primary, and Ley, Timothy J., primary

Published
2023
Full Text
View/download PDF

8. Supplementary Table from Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid Leukemia

Author

Petti, Allegra A., primary, Khan, Saad M., primary, Xu, Ziheng, primary, Helton, Nichole, primary, Fronick, Catrina C., primary, Fulton, Robert, primary, Ramakrishnan, Sai M., primary, Nonavinkere Srivatsan, Sridhar, primary, Heath, Sharon E., primary, Westervelt, Peter, primary, Payton, Jacqueline E., primary, Walter, Matthew J., primary, Link, Daniel C., primary, DiPersio, John, primary, Miller, Christopher, primary, and Ley, Timothy J., primary

Published
2023
Full Text
View/download PDF

9. Supplementary Table from Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid Leukemia

Author

Petti, Allegra A., primary, Khan, Saad M., primary, Xu, Ziheng, primary, Helton, Nichole, primary, Fronick, Catrina C., primary, Fulton, Robert, primary, Ramakrishnan, Sai M., primary, Nonavinkere Srivatsan, Sridhar, primary, Heath, Sharon E., primary, Westervelt, Peter, primary, Payton, Jacqueline E., primary, Walter, Matthew J., primary, Link, Daniel C., primary, DiPersio, John, primary, Miller, Christopher, primary, and Ley, Timothy J., primary

Published
2023
Full Text
View/download PDF

10. Supplementary Table from Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid Leukemia

Author

Petti, Allegra A., primary, Khan, Saad M., primary, Xu, Ziheng, primary, Helton, Nichole, primary, Fronick, Catrina C., primary, Fulton, Robert, primary, Ramakrishnan, Sai M., primary, Nonavinkere Srivatsan, Sridhar, primary, Heath, Sharon E., primary, Westervelt, Peter, primary, Payton, Jacqueline E., primary, Walter, Matthew J., primary, Link, Daniel C., primary, DiPersio, John, primary, Miller, Christopher, primary, and Ley, Timothy J., primary

Published
2023
Full Text
View/download PDF

11. Supplementary Data from Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid Leukemia

Author

Petti, Allegra A., primary, Khan, Saad M., primary, Xu, Ziheng, primary, Helton, Nichole, primary, Fronick, Catrina C., primary, Fulton, Robert, primary, Ramakrishnan, Sai M., primary, Nonavinkere Srivatsan, Sridhar, primary, Heath, Sharon E., primary, Westervelt, Peter, primary, Payton, Jacqueline E., primary, Walter, Matthew J., primary, Link, Daniel C., primary, DiPersio, John, primary, Miller, Christopher, primary, and Ley, Timothy J., primary

Published
2023
Full Text
View/download PDF

12. Supplementary Table from Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid Leukemia

Author

Petti, Allegra A., primary, Khan, Saad M., primary, Xu, Ziheng, primary, Helton, Nichole, primary, Fronick, Catrina C., primary, Fulton, Robert, primary, Ramakrishnan, Sai M., primary, Nonavinkere Srivatsan, Sridhar, primary, Heath, Sharon E., primary, Westervelt, Peter, primary, Payton, Jacqueline E., primary, Walter, Matthew J., primary, Link, Daniel C., primary, DiPersio, John, primary, Miller, Christopher, primary, and Ley, Timothy J., primary

Published
2023
Full Text
View/download PDF

13. Data from Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid Leukemia

Author

Petti, Allegra A., primary, Khan, Saad M., primary, Xu, Ziheng, primary, Helton, Nichole, primary, Fronick, Catrina C., primary, Fulton, Robert, primary, Ramakrishnan, Sai M., primary, Nonavinkere Srivatsan, Sridhar, primary, Heath, Sharon E., primary, Westervelt, Peter, primary, Payton, Jacqueline E., primary, Walter, Matthew J., primary, Link, Daniel C., primary, DiPersio, John, primary, Miller, Christopher, primary, and Ley, Timothy J., primary

Published
2023
Full Text
View/download PDF

14. Supplementary Table from Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid Leukemia

Author

Petti, Allegra A., primary, Khan, Saad M., primary, Xu, Ziheng, primary, Helton, Nichole, primary, Fronick, Catrina C., primary, Fulton, Robert, primary, Ramakrishnan, Sai M., primary, Nonavinkere Srivatsan, Sridhar, primary, Heath, Sharon E., primary, Westervelt, Peter, primary, Payton, Jacqueline E., primary, Walter, Matthew J., primary, Link, Daniel C., primary, DiPersio, John, primary, Miller, Christopher, primary, and Ley, Timothy J., primary

Published
2023
Full Text
View/download PDF

15. Supplementary Table from Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid Leukemia

Author

Petti, Allegra A., primary, Khan, Saad M., primary, Xu, Ziheng, primary, Helton, Nichole, primary, Fronick, Catrina C., primary, Fulton, Robert, primary, Ramakrishnan, Sai M., primary, Nonavinkere Srivatsan, Sridhar, primary, Heath, Sharon E., primary, Westervelt, Peter, primary, Payton, Jacqueline E., primary, Walter, Matthew J., primary, Link, Daniel C., primary, DiPersio, John, primary, Miller, Christopher, primary, and Ley, Timothy J., primary

Published
2023
Full Text
View/download PDF

16. Data from Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid Leukemia

Author

Petti, Allegra A., primary, Khan, Saad M., primary, Xu, Ziheng, primary, Helton, Nichole, primary, Fronick, Catrina C., primary, Fulton, Robert, primary, Ramakrishnan, Sai M., primary, Nonavinkere Srivatsan, Sridhar, primary, Heath, Sharon E., primary, Westervelt, Peter, primary, Payton, Jacqueline E., primary, Walter, Matthew J., primary, Link, Daniel C., primary, DiPersio, John, primary, Miller, Christopher, primary, and Ley, Timothy J., primary

Published
2023
Full Text
View/download PDF

17. Supplementary Data from Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid Leukemia

Author

Petti, Allegra A., primary, Khan, Saad M., primary, Xu, Ziheng, primary, Helton, Nichole, primary, Fronick, Catrina C., primary, Fulton, Robert, primary, Ramakrishnan, Sai M., primary, Nonavinkere Srivatsan, Sridhar, primary, Heath, Sharon E., primary, Westervelt, Peter, primary, Payton, Jacqueline E., primary, Walter, Matthew J., primary, Link, Daniel C., primary, DiPersio, John, primary, Miller, Christopher, primary, and Ley, Timothy J., primary

Published
2023
Full Text
View/download PDF

18. Supplementary Table 4 from Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity

Author

Zhang, Xiuli, primary, Kim, Samuel, primary, Hundal, Jasreet, primary, Herndon, John M., primary, Li, Shunqiang, primary, Petti, Allegra A., primary, Soysal, Savas D., primary, Li, Lijin, primary, McLellan, Mike D., primary, Hoog, Jeremy, primary, Primeau, Tina, primary, Myers, Nancy, primary, Vickery, Tammi L., primary, Sturmoski, Mark, primary, Hagemann, Ian S., primary, Miller, Chris A., primary, Ellis, Matthew J., primary, Mardis, Elaine R., primary, Hansen, Ted, primary, Fleming, Timothy P., primary, Goedegebuure, S. Peter, primary, and Gillanders, William E., primary

Published
2023
Full Text
View/download PDF

19. Data from Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity

Author

Zhang, Xiuli, primary, Kim, Samuel, primary, Hundal, Jasreet, primary, Herndon, John M., primary, Li, Shunqiang, primary, Petti, Allegra A., primary, Soysal, Savas D., primary, Li, Lijin, primary, McLellan, Mike D., primary, Hoog, Jeremy, primary, Primeau, Tina, primary, Myers, Nancy, primary, Vickery, Tammi L., primary, Sturmoski, Mark, primary, Hagemann, Ian S., primary, Miller, Chris A., primary, Ellis, Matthew J., primary, Mardis, Elaine R., primary, Hansen, Ted, primary, Fleming, Timothy P., primary, Goedegebuure, S. Peter, primary, and Gillanders, William E., primary

Published
2023
Full Text
View/download PDF

20. Supplementary Figures 1 - 5, Tables 1, 5 - 9 from Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity

Author

Zhang, Xiuli, primary, Kim, Samuel, primary, Hundal, Jasreet, primary, Herndon, John M., primary, Li, Shunqiang, primary, Petti, Allegra A., primary, Soysal, Savas D., primary, Li, Lijin, primary, McLellan, Mike D., primary, Hoog, Jeremy, primary, Primeau, Tina, primary, Myers, Nancy, primary, Vickery, Tammi L., primary, Sturmoski, Mark, primary, Hagemann, Ian S., primary, Miller, Chris A., primary, Ellis, Matthew J., primary, Mardis, Elaine R., primary, Hansen, Ted, primary, Fleming, Timothy P., primary, Goedegebuure, S. Peter, primary, and Gillanders, William E., primary

Published
2023
Full Text
View/download PDF

21. Supplementary Figures 1 - 5, Tables 1, 5 - 9 from Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity

Author

Zhang, Xiuli, primary, Kim, Samuel, primary, Hundal, Jasreet, primary, Herndon, John M., primary, Li, Shunqiang, primary, Petti, Allegra A., primary, Soysal, Savas D., primary, Li, Lijin, primary, McLellan, Mike D., primary, Hoog, Jeremy, primary, Primeau, Tina, primary, Myers, Nancy, primary, Vickery, Tammi L., primary, Sturmoski, Mark, primary, Hagemann, Ian S., primary, Miller, Chris A., primary, Ellis, Matthew J., primary, Mardis, Elaine R., primary, Hansen, Ted, primary, Fleming, Timothy P., primary, Goedegebuure, S. Peter, primary, and Gillanders, William E., primary

Published
2023
Full Text
View/download PDF

22. Data from Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity

Author

Zhang, Xiuli, primary, Kim, Samuel, primary, Hundal, Jasreet, primary, Herndon, John M., primary, Li, Shunqiang, primary, Petti, Allegra A., primary, Soysal, Savas D., primary, Li, Lijin, primary, McLellan, Mike D., primary, Hoog, Jeremy, primary, Primeau, Tina, primary, Myers, Nancy, primary, Vickery, Tammi L., primary, Sturmoski, Mark, primary, Hagemann, Ian S., primary, Miller, Chris A., primary, Ellis, Matthew J., primary, Mardis, Elaine R., primary, Hansen, Ted, primary, Fleming, Timothy P., primary, Goedegebuure, S. Peter, primary, and Gillanders, William E., primary

Published
2023
Full Text
View/download PDF

23. Supplementary Table 2 from Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity

Author

Zhang, Xiuli, primary, Kim, Samuel, primary, Hundal, Jasreet, primary, Herndon, John M., primary, Li, Shunqiang, primary, Petti, Allegra A., primary, Soysal, Savas D., primary, Li, Lijin, primary, McLellan, Mike D., primary, Hoog, Jeremy, primary, Primeau, Tina, primary, Myers, Nancy, primary, Vickery, Tammi L., primary, Sturmoski, Mark, primary, Hagemann, Ian S., primary, Miller, Chris A., primary, Ellis, Matthew J., primary, Mardis, Elaine R., primary, Hansen, Ted, primary, Fleming, Timothy P., primary, Goedegebuure, S. Peter, primary, and Gillanders, William E., primary

Published
2023
Full Text
View/download PDF

24. Supplementary Table 3 from Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity

Author

Zhang, Xiuli, primary, Kim, Samuel, primary, Hundal, Jasreet, primary, Herndon, John M., primary, Li, Shunqiang, primary, Petti, Allegra A., primary, Soysal, Savas D., primary, Li, Lijin, primary, McLellan, Mike D., primary, Hoog, Jeremy, primary, Primeau, Tina, primary, Myers, Nancy, primary, Vickery, Tammi L., primary, Sturmoski, Mark, primary, Hagemann, Ian S., primary, Miller, Chris A., primary, Ellis, Matthew J., primary, Mardis, Elaine R., primary, Hansen, Ted, primary, Fleming, Timothy P., primary, Goedegebuure, S. Peter, primary, and Gillanders, William E., primary

Published
2023
Full Text
View/download PDF

25. Supplementary Table 3 from Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity

Author

Zhang, Xiuli, primary, Kim, Samuel, primary, Hundal, Jasreet, primary, Herndon, John M., primary, Li, Shunqiang, primary, Petti, Allegra A., primary, Soysal, Savas D., primary, Li, Lijin, primary, McLellan, Mike D., primary, Hoog, Jeremy, primary, Primeau, Tina, primary, Myers, Nancy, primary, Vickery, Tammi L., primary, Sturmoski, Mark, primary, Hagemann, Ian S., primary, Miller, Chris A., primary, Ellis, Matthew J., primary, Mardis, Elaine R., primary, Hansen, Ted, primary, Fleming, Timothy P., primary, Goedegebuure, S. Peter, primary, and Gillanders, William E., primary

Published
2023
Full Text
View/download PDF

26. Supplementary Table 4 from Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity

Author

Zhang, Xiuli, primary, Kim, Samuel, primary, Hundal, Jasreet, primary, Herndon, John M., primary, Li, Shunqiang, primary, Petti, Allegra A., primary, Soysal, Savas D., primary, Li, Lijin, primary, McLellan, Mike D., primary, Hoog, Jeremy, primary, Primeau, Tina, primary, Myers, Nancy, primary, Vickery, Tammi L., primary, Sturmoski, Mark, primary, Hagemann, Ian S., primary, Miller, Chris A., primary, Ellis, Matthew J., primary, Mardis, Elaine R., primary, Hansen, Ted, primary, Fleming, Timothy P., primary, Goedegebuure, S. Peter, primary, and Gillanders, William E., primary

Published
2023
Full Text
View/download PDF

27. Supplementary Table 2 from Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity

Author

Zhang, Xiuli, primary, Kim, Samuel, primary, Hundal, Jasreet, primary, Herndon, John M., primary, Li, Shunqiang, primary, Petti, Allegra A., primary, Soysal, Savas D., primary, Li, Lijin, primary, McLellan, Mike D., primary, Hoog, Jeremy, primary, Primeau, Tina, primary, Myers, Nancy, primary, Vickery, Tammi L., primary, Sturmoski, Mark, primary, Hagemann, Ian S., primary, Miller, Chris A., primary, Ellis, Matthew J., primary, Mardis, Elaine R., primary, Hansen, Ted, primary, Fleming, Timothy P., primary, Goedegebuure, S. Peter, primary, and Gillanders, William E., primary

Published
2023
Full Text
View/download PDF

28. Table S1 from Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma

Author

Foltz, Jennifer A., primary, Hess, Brian T., primary, Bachanova, Veronika, primary, Bartlett, Nancy L., primary, Berrien-Elliott, Melissa M., primary, McClain, Ethan, primary, Becker-Hapak, Michelle, primary, Foster, Mark, primary, Schappe, Timothy, primary, Kahl, Brad, primary, Mehta-Shah, Neha, primary, Cashen, Amanda F., primary, Marin, Nancy D., primary, McDaniels, Kristen, primary, Moreno, Chaz, primary, Mosior, Matthew, primary, Gao, Feng, primary, Griffith, Obi L., primary, Griffith, Malachi, primary, Wagner, Julia A., primary, Epperla, Narendranath, primary, Rock, Amy D., primary, Lee, John, primary, Petti, Allegra A., primary, Soon-Shiong, Patrick, primary, and Fehniger, Todd A., primary

Published
2023
Full Text
View/download PDF

29. Figure S3 from Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma

Author

Foltz, Jennifer A., primary, Hess, Brian T., primary, Bachanova, Veronika, primary, Bartlett, Nancy L., primary, Berrien-Elliott, Melissa M., primary, McClain, Ethan, primary, Becker-Hapak, Michelle, primary, Foster, Mark, primary, Schappe, Timothy, primary, Kahl, Brad, primary, Mehta-Shah, Neha, primary, Cashen, Amanda F., primary, Marin, Nancy D., primary, McDaniels, Kristen, primary, Moreno, Chaz, primary, Mosior, Matthew, primary, Gao, Feng, primary, Griffith, Obi L., primary, Griffith, Malachi, primary, Wagner, Julia A., primary, Epperla, Narendranath, primary, Rock, Amy D., primary, Lee, John, primary, Petti, Allegra A., primary, Soon-Shiong, Patrick, primary, and Fehniger, Todd A., primary

Published
2023
Full Text
View/download PDF

30. Figure S2 from Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma

Author

Foltz, Jennifer A., primary, Hess, Brian T., primary, Bachanova, Veronika, primary, Bartlett, Nancy L., primary, Berrien-Elliott, Melissa M., primary, McClain, Ethan, primary, Becker-Hapak, Michelle, primary, Foster, Mark, primary, Schappe, Timothy, primary, Kahl, Brad, primary, Mehta-Shah, Neha, primary, Cashen, Amanda F., primary, Marin, Nancy D., primary, McDaniels, Kristen, primary, Moreno, Chaz, primary, Mosior, Matthew, primary, Gao, Feng, primary, Griffith, Obi L., primary, Griffith, Malachi, primary, Wagner, Julia A., primary, Epperla, Narendranath, primary, Rock, Amy D., primary, Lee, John, primary, Petti, Allegra A., primary, Soon-Shiong, Patrick, primary, and Fehniger, Todd A., primary

Published
2023
Full Text
View/download PDF

31. Figure S1 from Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma

Author

Foltz, Jennifer A., primary, Hess, Brian T., primary, Bachanova, Veronika, primary, Bartlett, Nancy L., primary, Berrien-Elliott, Melissa M., primary, McClain, Ethan, primary, Becker-Hapak, Michelle, primary, Foster, Mark, primary, Schappe, Timothy, primary, Kahl, Brad, primary, Mehta-Shah, Neha, primary, Cashen, Amanda F., primary, Marin, Nancy D., primary, McDaniels, Kristen, primary, Moreno, Chaz, primary, Mosior, Matthew, primary, Gao, Feng, primary, Griffith, Obi L., primary, Griffith, Malachi, primary, Wagner, Julia A., primary, Epperla, Narendranath, primary, Rock, Amy D., primary, Lee, John, primary, Petti, Allegra A., primary, Soon-Shiong, Patrick, primary, and Fehniger, Todd A., primary

Published
2023
Full Text
View/download PDF

32. Table S3 from Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma

Author

Foltz, Jennifer A., primary, Hess, Brian T., primary, Bachanova, Veronika, primary, Bartlett, Nancy L., primary, Berrien-Elliott, Melissa M., primary, McClain, Ethan, primary, Becker-Hapak, Michelle, primary, Foster, Mark, primary, Schappe, Timothy, primary, Kahl, Brad, primary, Mehta-Shah, Neha, primary, Cashen, Amanda F., primary, Marin, Nancy D., primary, McDaniels, Kristen, primary, Moreno, Chaz, primary, Mosior, Matthew, primary, Gao, Feng, primary, Griffith, Obi L., primary, Griffith, Malachi, primary, Wagner, Julia A., primary, Epperla, Narendranath, primary, Rock, Amy D., primary, Lee, John, primary, Petti, Allegra A., primary, Soon-Shiong, Patrick, primary, and Fehniger, Todd A., primary

Published
2023
Full Text
View/download PDF

33. Figure S2 from Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma

Author

Foltz, Jennifer A., primary, Hess, Brian T., primary, Bachanova, Veronika, primary, Bartlett, Nancy L., primary, Berrien-Elliott, Melissa M., primary, McClain, Ethan, primary, Becker-Hapak, Michelle, primary, Foster, Mark, primary, Schappe, Timothy, primary, Kahl, Brad, primary, Mehta-Shah, Neha, primary, Cashen, Amanda F., primary, Marin, Nancy D., primary, McDaniels, Kristen, primary, Moreno, Chaz, primary, Mosior, Matthew, primary, Gao, Feng, primary, Griffith, Obi L., primary, Griffith, Malachi, primary, Wagner, Julia A., primary, Epperla, Narendranath, primary, Rock, Amy D., primary, Lee, John, primary, Petti, Allegra A., primary, Soon-Shiong, Patrick, primary, and Fehniger, Todd A., primary

Published
2023
Full Text
View/download PDF

34. Figure S4 from Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma

Author

Foltz, Jennifer A., primary, Hess, Brian T., primary, Bachanova, Veronika, primary, Bartlett, Nancy L., primary, Berrien-Elliott, Melissa M., primary, McClain, Ethan, primary, Becker-Hapak, Michelle, primary, Foster, Mark, primary, Schappe, Timothy, primary, Kahl, Brad, primary, Mehta-Shah, Neha, primary, Cashen, Amanda F., primary, Marin, Nancy D., primary, McDaniels, Kristen, primary, Moreno, Chaz, primary, Mosior, Matthew, primary, Gao, Feng, primary, Griffith, Obi L., primary, Griffith, Malachi, primary, Wagner, Julia A., primary, Epperla, Narendranath, primary, Rock, Amy D., primary, Lee, John, primary, Petti, Allegra A., primary, Soon-Shiong, Patrick, primary, and Fehniger, Todd A., primary

Published
2023
Full Text
View/download PDF

35. Figure S4 from Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma

Author

Foltz, Jennifer A., primary, Hess, Brian T., primary, Bachanova, Veronika, primary, Bartlett, Nancy L., primary, Berrien-Elliott, Melissa M., primary, McClain, Ethan, primary, Becker-Hapak, Michelle, primary, Foster, Mark, primary, Schappe, Timothy, primary, Kahl, Brad, primary, Mehta-Shah, Neha, primary, Cashen, Amanda F., primary, Marin, Nancy D., primary, McDaniels, Kristen, primary, Moreno, Chaz, primary, Mosior, Matthew, primary, Gao, Feng, primary, Griffith, Obi L., primary, Griffith, Malachi, primary, Wagner, Julia A., primary, Epperla, Narendranath, primary, Rock, Amy D., primary, Lee, John, primary, Petti, Allegra A., primary, Soon-Shiong, Patrick, primary, and Fehniger, Todd A., primary

Published
2023
Full Text
View/download PDF

36. Table S3 from Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma

Author

Foltz, Jennifer A., primary, Hess, Brian T., primary, Bachanova, Veronika, primary, Bartlett, Nancy L., primary, Berrien-Elliott, Melissa M., primary, McClain, Ethan, primary, Becker-Hapak, Michelle, primary, Foster, Mark, primary, Schappe, Timothy, primary, Kahl, Brad, primary, Mehta-Shah, Neha, primary, Cashen, Amanda F., primary, Marin, Nancy D., primary, McDaniels, Kristen, primary, Moreno, Chaz, primary, Mosior, Matthew, primary, Gao, Feng, primary, Griffith, Obi L., primary, Griffith, Malachi, primary, Wagner, Julia A., primary, Epperla, Narendranath, primary, Rock, Amy D., primary, Lee, John, primary, Petti, Allegra A., primary, Soon-Shiong, Patrick, primary, and Fehniger, Todd A., primary

Published
2023
Full Text
View/download PDF

37. Figure S1 from Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma

Author

Foltz, Jennifer A., primary, Hess, Brian T., primary, Bachanova, Veronika, primary, Bartlett, Nancy L., primary, Berrien-Elliott, Melissa M., primary, McClain, Ethan, primary, Becker-Hapak, Michelle, primary, Foster, Mark, primary, Schappe, Timothy, primary, Kahl, Brad, primary, Mehta-Shah, Neha, primary, Cashen, Amanda F., primary, Marin, Nancy D., primary, McDaniels, Kristen, primary, Moreno, Chaz, primary, Mosior, Matthew, primary, Gao, Feng, primary, Griffith, Obi L., primary, Griffith, Malachi, primary, Wagner, Julia A., primary, Epperla, Narendranath, primary, Rock, Amy D., primary, Lee, John, primary, Petti, Allegra A., primary, Soon-Shiong, Patrick, primary, and Fehniger, Todd A., primary

Published
2023
Full Text
View/download PDF

38. Figure S3 from Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma

Author

Foltz, Jennifer A., primary, Hess, Brian T., primary, Bachanova, Veronika, primary, Bartlett, Nancy L., primary, Berrien-Elliott, Melissa M., primary, McClain, Ethan, primary, Becker-Hapak, Michelle, primary, Foster, Mark, primary, Schappe, Timothy, primary, Kahl, Brad, primary, Mehta-Shah, Neha, primary, Cashen, Amanda F., primary, Marin, Nancy D., primary, McDaniels, Kristen, primary, Moreno, Chaz, primary, Mosior, Matthew, primary, Gao, Feng, primary, Griffith, Obi L., primary, Griffith, Malachi, primary, Wagner, Julia A., primary, Epperla, Narendranath, primary, Rock, Amy D., primary, Lee, John, primary, Petti, Allegra A., primary, Soon-Shiong, Patrick, primary, and Fehniger, Todd A., primary

Published
2023
Full Text
View/download PDF

39. Table S2 from Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma

Author

Foltz, Jennifer A., primary, Hess, Brian T., primary, Bachanova, Veronika, primary, Bartlett, Nancy L., primary, Berrien-Elliott, Melissa M., primary, McClain, Ethan, primary, Becker-Hapak, Michelle, primary, Foster, Mark, primary, Schappe, Timothy, primary, Kahl, Brad, primary, Mehta-Shah, Neha, primary, Cashen, Amanda F., primary, Marin, Nancy D., primary, McDaniels, Kristen, primary, Moreno, Chaz, primary, Mosior, Matthew, primary, Gao, Feng, primary, Griffith, Obi L., primary, Griffith, Malachi, primary, Wagner, Julia A., primary, Epperla, Narendranath, primary, Rock, Amy D., primary, Lee, John, primary, Petti, Allegra A., primary, Soon-Shiong, Patrick, primary, and Fehniger, Todd A., primary

Published
2023
Full Text
View/download PDF

40. Table S1 from Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma

Author

Foltz, Jennifer A., primary, Hess, Brian T., primary, Bachanova, Veronika, primary, Bartlett, Nancy L., primary, Berrien-Elliott, Melissa M., primary, McClain, Ethan, primary, Becker-Hapak, Michelle, primary, Foster, Mark, primary, Schappe, Timothy, primary, Kahl, Brad, primary, Mehta-Shah, Neha, primary, Cashen, Amanda F., primary, Marin, Nancy D., primary, McDaniels, Kristen, primary, Moreno, Chaz, primary, Mosior, Matthew, primary, Gao, Feng, primary, Griffith, Obi L., primary, Griffith, Malachi, primary, Wagner, Julia A., primary, Epperla, Narendranath, primary, Rock, Amy D., primary, Lee, John, primary, Petti, Allegra A., primary, Soon-Shiong, Patrick, primary, and Fehniger, Todd A., primary

Published
2023
Full Text
View/download PDF

41. Table S2 from Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma

Author

Foltz, Jennifer A., primary, Hess, Brian T., primary, Bachanova, Veronika, primary, Bartlett, Nancy L., primary, Berrien-Elliott, Melissa M., primary, McClain, Ethan, primary, Becker-Hapak, Michelle, primary, Foster, Mark, primary, Schappe, Timothy, primary, Kahl, Brad, primary, Mehta-Shah, Neha, primary, Cashen, Amanda F., primary, Marin, Nancy D., primary, McDaniels, Kristen, primary, Moreno, Chaz, primary, Mosior, Matthew, primary, Gao, Feng, primary, Griffith, Obi L., primary, Griffith, Malachi, primary, Wagner, Julia A., primary, Epperla, Narendranath, primary, Rock, Amy D., primary, Lee, John, primary, Petti, Allegra A., primary, Soon-Shiong, Patrick, primary, and Fehniger, Todd A., primary

Published
2023
Full Text
View/download PDF

42. Supplemental Methods from Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma

Author

Foltz, Jennifer A., primary, Hess, Brian T., primary, Bachanova, Veronika, primary, Bartlett, Nancy L., primary, Berrien-Elliott, Melissa M., primary, McClain, Ethan, primary, Becker-Hapak, Michelle, primary, Foster, Mark, primary, Schappe, Timothy, primary, Kahl, Brad, primary, Mehta-Shah, Neha, primary, Cashen, Amanda F., primary, Marin, Nancy D., primary, McDaniels, Kristen, primary, Moreno, Chaz, primary, Mosior, Matthew, primary, Gao, Feng, primary, Griffith, Obi L., primary, Griffith, Malachi, primary, Wagner, Julia A., primary, Epperla, Narendranath, primary, Rock, Amy D., primary, Lee, John, primary, Petti, Allegra A., primary, Soon-Shiong, Patrick, primary, and Fehniger, Todd A., primary

Published
2023
Full Text
View/download PDF

43. Supplemental Methods from Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma

Author

Foltz, Jennifer A., primary, Hess, Brian T., primary, Bachanova, Veronika, primary, Bartlett, Nancy L., primary, Berrien-Elliott, Melissa M., primary, McClain, Ethan, primary, Becker-Hapak, Michelle, primary, Foster, Mark, primary, Schappe, Timothy, primary, Kahl, Brad, primary, Mehta-Shah, Neha, primary, Cashen, Amanda F., primary, Marin, Nancy D., primary, McDaniels, Kristen, primary, Moreno, Chaz, primary, Mosior, Matthew, primary, Gao, Feng, primary, Griffith, Obi L., primary, Griffith, Malachi, primary, Wagner, Julia A., primary, Epperla, Narendranath, primary, Rock, Amy D., primary, Lee, John, primary, Petti, Allegra A., primary, Soon-Shiong, Patrick, primary, and Fehniger, Todd A., primary

Published
2023
Full Text
View/download PDF

44. Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid Leukemia

Author

Petti, Allegra A., primary, Khan, Saad M., additional, Xu, Ziheng, additional, Helton, Nichole, additional, Fronick, Catrina C., additional, Fulton, Robert, additional, Ramakrishnan, Sai M., additional, Nonavinkere Srivatsan, Sridhar, additional, Heath, Sharon E., additional, Westervelt, Peter, additional, Payton, Jacqueline E., additional, Walter, Matthew J., additional, Link, Daniel C., additional, DiPersio, John, additional, Miller, Christopher, additional, and Ley, Timothy J., additional

Published
2021
Full Text
View/download PDF

45. Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma

Author

Foltz, Jennifer A., primary, Hess, Brian T., additional, Bachanova, Veronika, additional, Bartlett, Nancy L., additional, Berrien-Elliott, Melissa M., additional, McClain, Ethan, additional, Becker-Hapak, Michelle, additional, Foster, Mark, additional, Schappe, Timothy, additional, Kahl, Brad, additional, Mehta-Shah, Neha, additional, Cashen, Amanda F., additional, Marin, Nancy D., additional, McDaniels, Kristen, additional, Moreno, Chaz, additional, Mosior, Matthew, additional, Gao, Feng, additional, Griffith, Obi L., additional, Griffith, Malachi, additional, Wagner, Julia A., additional, Epperla, Narendranath, additional, Rock, Amy D., additional, Lee, John, additional, Petti, Allegra A., additional, Soon-Shiong, Patrick, additional, and Fehniger, Todd A., additional

Published
2021
Full Text
View/download PDF

46. Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity

Author

Zhang, Xiuli, primary, Kim, Samuel, additional, Hundal, Jasreet, additional, Herndon, John M., additional, Li, Shunqiang, additional, Petti, Allegra A., additional, Soysal, Savas D., additional, Li, Lijin, additional, McLellan, Mike D., additional, Hoog, Jeremy, additional, Primeau, Tina, additional, Myers, Nancy, additional, Vickery, Tammi L., additional, Sturmoski, Mark, additional, Hagemann, Ian S., additional, Miller, Chris A., additional, Ellis, Matthew J., additional, Mardis, Elaine R., additional, Hansen, Ted, additional, Fleming, Timothy P., additional, Goedegebuure, S. Peter, additional, and Gillanders, William E., additional

Published
2017
Full Text
View/download PDF

47. Abstract PR11: Genomic approaches for risk assessment in acute myeloid leukemia

Author

Klco, Jeffery M., primary, Miller, Christopher A., additional, Griffith, Malachi, additional, Petti, Allegra, additional, Spencer, David H., additional, Ketkar-Kulkarni, Shamika, additional, Wartman, Lukas D., additional, Christopher, Matthew, additional, Lamprecht, Tamara L., additional, Payton, Jacqueline E., additional, Baty, Jack, additional, Heath, Sharon E., additional, Griffith, Obi L., additional, Shen, Dong, additional, Hundal, Jasreet, additional, Chang, Gue Su, additional, Fulton, Robert S., additional, O'laughlin, Michelle, additional, Fronick, Catrina, additional, Magrini, Vincent, additional, Demeter, Ryan, additional, Larson, David E., additional, Kulkarni, Shashikant, additional, Ozenberger, Bradley A., additional, Welch, John S., additional, Walker, Matthew J., additional, Graubert, Timothy A., additional, Westervelt, Peter, additional, Radich, Jerald P., additional, Link, Daniel C., additional, Mardis, Elaine R., additional, DiPersio, John F., additional, and Wilson, Richard K., additional

Published
2015
Full Text
View/download PDF

48. Abstract PR03: Genomic approaches for risk assessment in acute myeloid leukemia

Author

Klco, Jeffery M., primary, Miller, Christopher A., additional, Griffith, Malachi, additional, Petti, Allegra, additional, Spencer, David H., additional, Ketkar-Kulkarni, Shamika, additional, Wartman, Lukas D., additional, Christopher, Matthew, additional, Lamprecht, Tamara L., additional, Payton, Jacqueline E., additional, Baty, Jack, additional, Heath, Sharon E., additional, Griffith, Obi L., additional, Shen, Dong, additional, Hundal, Jasreet, additional, Chang, Gue Su, additional, Fulton, Robert S., additional, O'laughlin, Michelle, additional, Fronick, Catrina, additional, Magrini, Vincent, additional, Demeter, Ryan, additional, Larson, David E., additional, Kulkarni, Shashikant, additional, Ozenberger, Bradley A., additional, Welch, John S., additional, Walker, Matthew J., additional, Graubert, Timothy A., additional, Westervelt, Peter, additional, Radich, Jerald P., additional, Link, Daniel C., additional, Mardis, Elaine R., additional, DiPersio, John F., additional, and Wilson, Richard K., additional

Published
2015
Full Text
View/download PDF

49. Abstract LB-237: Vaccination increases the breadth and diversity of melanoma neoantigen-specific T cells in humans

Author

Carreno, Beatriz M., primary, Magrini, Vincent, additional, Becker-Hapak, Michelle, additional, Kaabinejadian, Saghar, additional, Hundal, Jasreet, additional, Petti, Allegra A., additional, Ly, Amy, additional, Lie, Wen-Rong, additional, Hildebrand, William H., additional, Mardis, Elaine R., additional, and Linette, Gerald P., additional

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results